While the clinical characteristics of SSc patients with anti‐SSA seropositivity have been reported in SSc [8, 9, 10], our data suggest that the absence of concomitant SSc‐related autoantibodies may mark a unique subgroup with particularly aggressive disease trajectories from a longitudinal observation of a Japanese cohort. This evidence concerns the gene TRIM21 and systemic sclerosis.